Latest Ryman news

Podcast #12 - Alzheimer’s Breakthrough

Written by Dr Doug Wilson
on May 30, 2020

Episode 12 Alzheimer’s Breakthrough

Dr Doug and Dave reveal an exciting breakthrough in the search for a more effective drug for Alzheimer’s disease.

Listen closely to learn the ins and outs of the science behind Alzheimer's, dementia, and the journey currently being taken to develop a new drug. The science is complex, but don’t worry if words like beta-amyloid cause you to yawn because Dr Doug breaks down the science for everybody to understand with ease. This podcast provides an in-depth look at how Alzheimer's drugs and our understanding of the disease has developed over the years and why an effective drug is proving to be such a challenge for the drug making industry.

Listen now


About Ryman Healthcare:

Ryman was founded in 1984 and has become one of New Zealand’s largest listed companies. The company owns and operates 45 retirement villages in New Zealand and Australia which are home to more than 13,900 residents and the company employs 6,800 team members.

Media advisory: For further information, photos, interviews or comment please contact Group Corporate Affairs Manager Silke Marsh on +64 27 294 3609 or Communications Advisor Maryvonne Gray on 027 552 0767.

You may also like: